Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury
Open Access
- 1 January 2007
- journal article
- Published by Springer Nature in BMC Immunology
- Vol. 8 (1) , 5
Abstract
The active form of vitamin D (1,25(OH)2D3) has been shown to inhibit development of inflammatory bowel disease (IBD) in IL-10 KO mice. Here, the role of the vitamin D receptor (VDR) and 1,25(OH)2D3 in acute experimental IBD was probed.Keywords
This publication has 42 references indexed in Scilit:
- Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial ResponseScience, 2006
- Vitamin D receptor is required to control gastrointestinal immunity in IL‐10 knockout miceImmunology, 2006
- Effects ofBoswellia serratain mouse models of chemically induced colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel diseaseEuropean Journal of Immunology, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Role of chemokines and chemokine receptors in the gastrointestinal tractImmunology, 2002
- Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?Proceedings of the Society for Experimental Biology and Medicine, 2000
- Role of Cytokines in the Pathogenesis of Inflammatory Bowel DiseaseAnnual Review of Medicine, 2000
- Significance of systemic endotoxaemia in inflammatory bowel disease.Gut, 1995
- The Role of Vitamin D in Bone and Intestinal Cell DifferentiationAnnual Review of Nutrition, 1990